As many Asian countries continue to enter aging societies, knee pain, degenerative joint concerns, and the maintenance of mobility have become important topics in health management and preventive medicine. For individuals seeking to maintain mobility and extend healthy life expectancy, knee joint care is attracting increasing attention.

In recent years, Japan’s regenerative medicine sector has continued to develop in areas such as regulatory management, medical processes, cell processing, and clinical application. It has also gained growing interest from the international healthcare and health management markets. In the orthopedic field, regenerative medicine-related technologies are being applied in areas such as knee joint care, mobility support, and health management.

Related medical approaches include cell-based therapies, PRP (Platelet-Rich Plasma), SVF (Stromal Vascular Fraction), ACRS, and cell culture supernatant-related regenerative medicine applications, offering additional medical consultation options and treatment planning possibilities for knee-related concerns.

Unlike single-treatment approaches, Japanese medical institutions place strong emphasis on physician evaluation, individualized treatment planning, medical safety management, and long-term health management. Through detailed examinations and professional diagnosis, physicians can provide appropriate medical advice based on each patient’s age, joint condition, lifestyle, and treatment needs.

As an important biotechnology and healthcare platform in Asia, BIO Asia–Taiwan provides valuable opportunities for exchange in regenerative medicine, health management, and international medical collaboration. Looking ahead, as the demand for healthy aging continues to grow, Japanese regenerative medicine and knee joint care are expected to become important areas for medical collaboration between Japan, Taiwan, and the broader Asian market.